FAS and lymphoma: Together, these results confirm that signaling events triggered upon the binding of sCD154 to α5β1 of leukemia or lymphoma T cell lines, leads to the inhibition of Fas-induced cell death, a phenomenon that plays a key role in the progression of malignancies, and particularly here of T cell origin.